Early studies show vaccines are less effective against a South African variant.
Johnson & Johnson vaccine 'highly effective'...
Biden is ramping up the vaccine supply, but questions remain about state’s ability to give shots
Two Hot Dogs And A Shot, Please! From Fenway Park To Hospitals, More Vaccinations Get Under Way
Massachusetts Gov. Charlie Baker detailed on Monday plans to have 103 public vaccination sites open by the end of the week. Suzanne Salamon, MD (Geriatric Medicine, BIDMC) has been taking a lot of calls from patients who are curious about how and when they can get the vaccine and said the public vaccination sites will be a tremendous boost for people who live in independent housing and have been confined in their houses or their apartments.
1,400 prisoners in Massachusetts have gotten the coronavirus vaccine, and officials are holding vaccine education programs to encourage more to do the same. Kathryn Stephenson, MD, MPH (Center for Virology and Vaccine Research, BIDMC) is among those working on getting more information to prisoners to address their concerns.
Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) spoke about how the COVID-19 pandemic has unfolded globally, the Johnson & Johnson vaccine candidate, and new virus strains.
President Biden’s goal of 100 million shots in 100 days may be hindered by the lack of vaccine doses. Public health officials are eagerly awaiting late-stage trial results for the one-dose vaccine candidate developed by Johnson & Johnson in collaboration with BIDMC.
Experts welcomed Moderna’s announcement that the company’s vaccine would protect people against variants of the virus that recently emerged in Britain and South Africa but concerns about the vaccine being less effective against the South Africa variant remain. Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) was more cautious in his assessment of the announcement from Moderna and noted it’s premature to read too much into the study.